Teva Slams Eli Lilly's 'Free Ride' On Migraine IP As Trial Opens
Teva Pharmaceuticals kicked off its migraine drug patent infringement trial against Eli Lilly and Co. on Wednesday, telling a Boston federal jury that the rival shouldn't be allowed to "free ride"...To view the full article, register now.
Already a subscriber? Click here to view full article